Uncovering Mechanisms of Replication in HPV
News May 22, 2015
Northwestern Medicine scientists have identified proteins that mediate aspects of virus replication in the lifecycle of human papillomavirus (HPV), a finding that may lead to new therapeutic targets for treatment of infections caused by the virus.
“What we show, for the first time, are the proteins that hold chromatin together during mitosis, or cell replication, are the same proteins that play an important role in the DNA damage response in these viral infections,” said Laimonis Laimins, Ph.D., chair of Microbiology-Immunology.
The study describes two cell proteins as critical regulators of viral replication; SMC1, a protein that bridges DNA together when cells divide, and CTCF, a protein that binds together strands of DNA to form loops that can either repress or enhance gene expression.
When the scientists reduce the genetic expression of these proteins, they found HPV was unable to replicate. They also confirmed that CTCF and SMC1 binding was critical to genome amplification, through mutating CTCF sites on the HPV genome. Reduction in the expression of CTCF resulted in the loss of the ability for SMC1 to interact with the HPV genome.
“This research is interesting because it show the ways in which the virus may interact with our own DNA,” said Kavi Mehta, first author of the paper and a third-year graduate student in the Walter S. and Lucienne Driskill Graduate Program in Life Sciences. “The importance of this research is understanding the life cycle of this virus. Now that we have a little bit of a greater understanding of how the virus maintains itself through the cell lifecycle, we might be able to find ways to prevent or understand how the virus evades the immune system.”
Next, Mehta plans to investigate how HPV uses these proteins to bring in other factors that allow the virus to replicate.
“These are small steps to figuring out this entire virus life cycle that is important for HPV biology,” Mehta said. “Once we know more about that, then this knowledge could be used as a base for developing therapeutics.”
Computation and Chemistry Combine to Create World-First Auxetic ProteinNews
A team of chemists at the University of California, San Diego (UCSD) has now designed a two-dimensional protein crystal that toggles between states of varying porosity and density. This is a first in biomolecular design that combined experimental studies with computation done on supercomputers. The research, published in April 2018 in Nature Chemistry, could help create new materials for renewable energy, medicine, water purification, and more.
Fructose Formula Poses Risk to Babies With Metabolic DisorderNews
Babies with inherited intolerance of fructose face a risk of acute liver failure if they are fed certain widely available formulas containing fructose, pediatricians and geneticists are warning. Baby formula manufacturers should remove fructose or sucrose, or explicitly label their products to allow parents to avoid those sweeteners if necessary, the doctors say.
Abzena Selects Sartorius Stedim Biotech to Equip its US Based Development and Manufacturing SitesNews
Abzena plc, the life sciences group providing services and technologies to enable the development and manufacture of biopharmaceutical products, has selected Sartorius Stedim Biotech as its preferred equipment supplier in the U.S.READ MORE